CIBC Private Wealth Group
LUCD icon

CIBC Private Wealth Group’s Lucid Diagnostics LUCD Stock Holding History

CIBC Private Wealth Group’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-315
Closed -$259 – 3216
2024
Q2 		$259 Hold
315
– – ﹤0.01% 3038
2024
Q1 		$283 Buy
+315
New +$409 ﹤0.01% 2970

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group's LUCD Position: Q3 2024 in Review

CIBC Private Wealth Group sold out of Lucid Diagnostics (LUCD) in Q3 2024, closing a stake of 315 shares — an estimated $259 sold.

CIBC Private Wealth Group first reported a position in LUCD in Q1 2024 and held it in 2 quarters. The position peaked at $283 in Q1 2024. 29 funds tracked by Wall St. Rank hold LUCD as of Q3 2024.

  • CIBC Private Wealth Group reported no remaining Lucid Diagnostics position as of Q3 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 315 Lucid Diagnostics shares in Q3 2024, an estimated $259.
  • CIBC Private Wealth Group first reported a position in Lucid Diagnostics in Q1 2024 and held it in 2 quarters.
  • CIBC Private Wealth Group's Lucid Diagnostics position peaked at $283 in Q1 2024.
  • 29 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2024.

Based on CIBC Private Wealth Group's 13F filing for Q3 2024, filed 13 Nov 2024.